Physician profile
Christopher J Williams
NPI 1568729713
$652.54
in general payments reported to CMS, 2019-2025
10 companies · $40.70 in 2025
The $40.70 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.32 · 2020: $57.45 · 2022: $252 · 2023: $81.64 · 2024: $207 · 2025: $40.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $331.48 | 2022-2025 | General - Pain Management |
| Scilex Pharmaceuticals INC. | $131.18 | 2022-2023 | Ztlido |
| Bioventus LLC | $37.82 | 2020 | |
| Ibsa Pharma INC. | $31.92 | 2022 | |
| Laborie Medical Technologies Corp. | $26.20 | 2024 | Endosheath Technology |
| Trevena, INC. | $22.94 | 2023 | Olinvyk |
| Abbvie INC. | $19.74 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $19.63 | 2020 | |
| Curonix LLC | $18.31 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.